FolioMetrix’s ANI Pharmaceuticals ANIP Stock Holding History

FolioMetrix’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,100	Closed	-$382K	–	220
2015 Q1	$382K	Buy	+6,100	New	+$371K	0.19%	106

Other funds holding ANIP

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

TCM

Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

FolioMetrix's ANIP Position: Q2 2015 in Review

FolioMetrix sold out of ANI Pharmaceuticals (ANIP) in Q2 2015, closing a stake of 6,100 shares — an estimated $382K sold.

FolioMetrix first reported a position in ANIP in Q1 2015 and held it in 1 quarter. The position peaked at $382K in Q1 2015. 123 funds tracked by Wall St. Rank hold ANIP as of Q2 2015.

FolioMetrix reported no remaining ANI Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
FolioMetrix sold 6,100 ANI Pharmaceuticals shares in Q2 2015, an estimated $382K.
FolioMetrix first reported a position in ANI Pharmaceuticals in Q1 2015 and held it in 1 quarter.
FolioMetrix's ANI Pharmaceuticals position peaked at $382K in Q1 2015.
123 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.